Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pulse Biosciences CS (NQ: PLSE )

7.750 -0.070 (-0.90%)
Streaming Delayed Price Updated: 9:30 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,089
Open 7.750
Bid (Size) 7.570 (4)
Ask (Size) 7.750 (1)
Prev. Close 7.820
Today's Range 7.750 - 7.750
52wk Range 3.780 - 13.62
Shares Outstanding 54,902,942
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga

Performance

YTD
-29.67%
-29.67%
1 Month
-20.92%
-20.92%
3 Month
-5.83%
-5.83%
6 Month
+82.78%
+82.78%
1 Year
+33.39%
+33.39%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Plans to Initiate a Rights Offering
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
From Pulse Biosciences, Inc.
Via Business Wire
Earnings Scheduled For March 28, 2024
Via Benzinga
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
From Pulse Biosciences, Inc.
Via Business Wire
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures Product Safety
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
From Pulse Biosciences, Inc.
Via Business Wire
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
From Pulse Biosciences, Inc.
Via Business Wire
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
Via Benzinga
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Insiders Buying Dave And 2 Other Stocks
Via Benzinga
Insiders Buying Westrock Coffee And 3 Other Stocks
Via Benzinga
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Earnings Scheduled For November 13, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.